Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.84 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.84 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.84 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.84 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.84 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.84 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.84 |
| ▸ | FTO | Q9C0B1 | 6/20 | 0.84 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.84 |
| ▸ | XDH | P47989 | 6/20 | 0.84 |
| ▸ | MAPT | P10636 | 5/20 | 0.84 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.84 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.84 |
| ▸ | APP | P05067 | 5/20 | 0.84 |
| ▸ | BCHE | P06276 | 4/20 | 0.84 |
| ▸ | ACHE | P22303 | 4/20 | 0.84 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.84 |
| ▸ | TP53 | P04637 | 4/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kaempferol SCHEMBL30864674 | 1.00 | MEN1 (0.84) | MEN1KMT2ACYP1A2ABCB1CYP3A4 | |
| Kaempferol SCHEMBL30655455 | 0.91 | MEN1 (1.00) | MEN1KMT2ACYP1A2ABCB1CYP3A4 | |
| Kaempferol SCHEMBL1259228 | 0.91 | MEN1 (1.00) | MEN1KMT2ACYP1A2ABCB1CYP3A4 | |
| Kaempferol SCHEMBL18817 | 0.91 | MEN1 (1.00) | MEN1KMT2ACYP1A2ABCB1CYP3A4 | |
| Kaempferol SCHEMBL29378805 | 0.91 | MEN1 (1.00) | MEN1KMT2ACYP1A2ABCB1CYP3A4 | |
| Kaempferol SCHEMBL31749037 | 0.90 | MEN1 (0.97) | MEN1KMT2ACYP1A2ABCB1CYP3A4 | |
| Kaempferol SCHEMBL34461912 | 0.90 | MEN1 (0.97) | MEN1KMT2ACYP1A2ABCB1CYP3A4 | |
| Kaempferol SCHEMBL31256029 | 0.90 | MEN1 (0.97) | MEN1KMT2ACYP1A2ABCB1CYP3A4 | |
| Kaempferol SCHEMBL17237761 | 0.90 | MEN1 (0.97) | MEN1KMT2ACYP1A2ABCB1CYP3A4 | |
| Kaempferol SCHEMBL38651062 | 0.90 | MEN1 (0.97) | MEN1KMT2ACYP1A2ABCB1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1245230-A2 | Amentoflavone as an antiviral agent | Advanced Life Sciences Inc. (US) | 2002-10-02 | — | — | EP | disclosed |
| US-20020068757-A1 | Biflavanoids and derivatives thereof as antiviral agents | ADVANCED LIFE SCIENCES, INC. | 2002-06-06 | — | — | US | disclosed |
| US-6399654-B1 | ADMINISTERING MIXTURE OF VIRICIDE AND BIOFLAVANOID | ADVANCED LIFE SCIENCES, INC. | 2002-06-04 | — | — | US | disclosed |
| US-5948918-A | PLANT EXTRACTS | MEDICHEM RESEARCH, INC. (US) | 1999-09-07 | — | — | US | disclosed |
| US-5773462-A | INFLUENZA THERAPY | MEDICHEM RESEARCH, INC. (US) | 1998-06-30 | — | — | US | disclosed |
| WO-1997000679-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1997-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068757-A1 | Biflavanoids and derivatives thereof as antiviral agents | HK2, GYS2, HK1 | MEN1 836/4885KMT2A 463/4885CYP1A2 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.